EHR Systems and Blockchain: Potentials, Challenges and the Road AheadJim Poteet | Sr. Director, Revenue Cycle Development, OracleMike Gault | CEO, GuardtimeDr. Anjum Khurshid | Chief Data Scientist, Harvard Pilgrim Health Care InstituteSivagnanam Suresh | Founder, VdocDr. Alex Norta | Founder, Norta Partners OÜHorst Treiblmaier, PhD | Head of the School of International Management, Modul University Vienna // ModeratorPanelists discuss blockchain technology use for electronic health records, and specifically delve into the benefits that blockchain brings to EHRs, but also discuss what its pitfalls and limitations are; including presenting perspectives from academia, and examples from practitioners, to ensure a lively discussion.Learning ObjectivesUnderstand the potential applications of blockchain for electronic health records (EHRs).Explore the benefits and challenges of implementing blockchain for EHRs, including security, interoperability, privacy, and data integrity.Identify key use cases and real-world examples of blockchain implementation in healthcare and EHR management.Analyze the potential impact of blockchain on improving healthcare data exchange, patient consent management, and medical research.Discuss the regulatory and legal considerations associated with using blockchain in healthcare, such as compliance with data protection laws and standards.Examine the role of smart contracts and decentralized applications (DApps) in enhancing EHR management and patient control over their health information.Assess the scalability and performance limitations of blockchain technology in handling large-scale healthcare data and high transaction volumes.Evaluate potential cost savings and efficiency gains achieved through blockchain implementation in EHRs, considering factors such as data access, auditability, and administrative overhead.Discuss the future prospects and challenges of integrating blockchain with existing healthcare systems, standards, and infrastructure to achieve widespread adoption and interoperability.
Metaverse in Health: Risks and OpportunitiesLisa Gus | CEO, WishKnish, Metaverse Standards ForumDr. Jane Thomason | Chair, Metaverse Council and Founder, Supernova DataThe train has left the station, and all we can do is “lean in, because you can’t stop the pace of progress.” What’s the best course for healthcare professionals to navigate tech advances: proceed slowly,and keep curiosity high. Speakers will discuss aspects to consider in securing a trusted metaverse reality that includes issues such as mental health, gamification, patient populations, market access and cost, the dangers of creating a have and have not economy, behavioral health impact, and the need to standardize safety first in a data economy
PharmaLedger Association – Platform Launch Lessons Learned and OutlookNatalia Sofia | Web3 AdvocateDaniel Fritz | Executive Director, PharmaLedgerDisa Lee Choun | Head of Integrated Clinical and Operational Analytics, Janssen PharmaceuticalsAnca Petre | CEO, Medrise Studio ModeratorDescription This panel will explore the application of blockchain technology within the healthcare sector, focusing on its potential to enhance trust, transparency, and connectivity while reinforcing patient-centered control of data access. The discussion will examine the opportunities for patient empowerment and improved patient access to healthcare information through decentralized ledger technology. The panel will feature industry experts who will provide insights into current trends, challenges, and future prospects of blockchain in pharmaceuticals, emphasizing broader use cases beyond specific organizations. Objectives1. Gain a comprehensive understanding of the role of blockchain technology in the pharmaceutical industry and its potential impact on patient care and relationships with the healthcare system.2. Explore the opportunities presented by blockchain for improving trust, transparency, and audibility in data sharing within the healthcare and medical environment.3. Understand the significance of patient-centered control in accessing, storing, and utilizing healthcare data and how blockchain can contribute to enhancing patient empowerment.4. Discuss the challenges and considerations associated with implementing blockchain in the pharmaceutical sector and explore strategies to overcome them while ensuring compliance with regulatory frameworks.
Distributed Manufacturing in MedicineNick Lambert | CEO, Dock LabsJim Nasr | CEO, Acoer ModeratorThe conversation pivots around what is actually working now in the blockchain in healthcare field including:Current trends in DIDs…what’s working, what’s notUsability and walletsBlockchain for medicine – is it helping decrease counterfeit medicine production?Decentralization, collaboration, and efficiencyAdvantages & disadvantages on decentralizing Pharma manufacturingImplications of collaborations, cross-border transactions for blockchain-enabled transactions and impact of immutabilityInteroperability, scalability, and economic viability for life sciencesRegulation and the implications in life sciencesTokenization & Web 3 trendsHow to increase adoption and what the incentives are for PharmaPrediction(s)
Pioneering New Business Models in Value Based CareAhmed Abdulla | CEO, DigipharmWe explore the real-world impact value-based procurement and subsequent contracting, and health technology pricing in the context of value-based care. We will delve into innovative business models that are reshaping the healthcare landscape, promoting cost-effectiveness, and enhancing patient outcomes. Attendees will gain valuable insights into the evolving strategies driving value-based care and its implications for healthcare providers, payers, and patients.Learning ObjectivesUnderstand the concept of value-based care and its significance in the current healthcare environment.Explore the real-world impact of value-based pricing on healthcare delivery and patient outcomes.Examine the role of value-based procurement/contracting in driving cost-effective healthcare solutions.Gain insights into health technology pricing models and their impact on value-based care initiatives.Identify innovative business models that support value-based care and improve patient outcomes.